Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Boccuzzi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: a pharmaceutical industry perspectiveS J Boccuzzi
Clinical Therapeutics|April 1, 2000
Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medicationsS J Boccuzzi, J Wogen, J B Roehm
The American Journal of Medicine|August 1, 1995
Prognosis after hospitalization for acute myocardial infarction not accompanied by typical ischemic chest pain. The Multicenter Diltiazem Postinfarction Trial Research GroupR E Goldstein, S J Boccuzzi, D Cruess
Navy Medicine|January 1, 1989
Food handlers: a potential high risk group for hypercholesterolemiaR W Savage, K Lee, C Condlin, et al.
Circulation|January 1, 1991
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research GroupR E Goldstein, S J Boccuzzi, D Cruess, et al.
The American Journal of Cardiology|June 15, 1989
Noninvasive and angiographic evaluation of coronary artery disease in patients with peripheral vascular diseaseD J Youngman, T Dove, S J Boccuzzi, et al.
The American Journal of Cardiology|January 15, 1996
Costs of coronary restenosis (Lovastatin Restenosis Trial)S P Gilbert, W S Weintraub, J D Talley, et al.
Circulation|November 1, 1995
Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudyD Waters, L Higginson, P Gladstone, et al.
Pharmacoeconomics|August 18, 2000
Household income losses associated with ischaemic heart disease for US employeesJ Herrin, C B Cangialose, S J Boccuzzi, et al.
Clinical Therapeutics|January 30, 2002
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classesP R Conlin, W C Gerth, J Fox, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
American Heart Journal|April 30, 1999
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: a pharmaceutical industry perspectiveS J Boccuzzi
Clinical Therapeutics|April 1, 2000
Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medicationsS J Boccuzzi, J Wogen, J B Roehm
The American Journal of Medicine|August 1, 1995
Prognosis after hospitalization for acute myocardial infarction not accompanied by typical ischemic chest pain. The Multicenter Diltiazem Postinfarction Trial Research GroupR E Goldstein, S J Boccuzzi, D Cruess
Navy Medicine|January 1, 1989
Food handlers: a potential high risk group for hypercholesterolemiaR W Savage, K Lee, C Condlin, et al.
Circulation|January 1, 1991
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research GroupR E Goldstein, S J Boccuzzi, D Cruess, et al.
The American Journal of Cardiology|June 15, 1989
Noninvasive and angiographic evaluation of coronary artery disease in patients with peripheral vascular diseaseD J Youngman, T Dove, S J Boccuzzi, et al.
The American Journal of Cardiology|January 15, 1996
Costs of coronary restenosis (Lovastatin Restenosis Trial)S P Gilbert, W S Weintraub, J D Talley, et al.
Circulation|November 1, 1995
Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudyD Waters, L Higginson, P Gladstone, et al.
Pharmacoeconomics|August 18, 2000
Household income losses associated with ischaemic heart disease for US employeesJ Herrin, C B Cangialose, S J Boccuzzi, et al.
Clinical Therapeutics|January 30, 2002
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classesP R Conlin, W C Gerth, J Fox, et al.
Pageof 4